| Date Filed | Type | Description |
| 08/25/2023 |
4
| Sarena Francis Willard (President and COO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Paid exercise price by delivering 31,123 shares
@ $0.3851, valued at
$12k
Disposed/sold 124,296 shares
@ $0
Disposed/sold 269,847 options to buy
@ $4.79, valued at
$1.3M
|
|
| 05/25/2023 |
4
| Sarena Francis Willard (President and COO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 150,000 shares
@ $0
Paid exercise price by delivering 20,748 shares
@ $0.4, valued at
$8.3k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2022 |
4
| Sarena Francis Willard (COO) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 08/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/19/2021 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Gifted 2,385 shares
@ $0
Gifted 795 shares
@ $0
Gifted 1,440 shares
@ $0
Gifted 2,460 shares
@ $0
Gifted 14,174 shares
@ $0
Granted 66,000 shares
@ $0
Disposed/sold 169,468 shares
@ $38, valued at
$6.4M
Disposed/sold 795 shares
@ $38, valued at
$30.2k
Disposed/sold 4,747 options to buy
@ $8.49, valued at
$40.3k
Disposed/sold 9,142 options to buy
@ $5.54, valued at
$50.6k
Disposed/sold 12,063 options to buy
@ $7.26, valued at
$87.6k
|
|
| 03/02/2021 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 1,158 shares
@ $22.23, valued at
$25.7k
|
|
| 02/26/2021 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 5,100 shares
@ $25.71, valued at
$131.1k
Paid exercise price by delivering 1,653 shares
@ $23.08, valued at
$38.2k
|
|
| 12/15/2020 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,583 shares
@ $16.14, valued at
$186.9k
Exercised 22,000 options to buy
@ $0 |
|
| 11/13/2020 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 11,001 shares
@ $18, valued at
$198k
Exercised 22,000 options to buy
@ $0 |
|
| 02/26/2020 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Granted 15,000 shares
@ $0
Paid exercise price by delivering 1,863 shares
@ $4.87, valued at
$9.1k
Paid exercise price by delivering 1,304 shares
@ $4.83, valued at
$6.3k
Granted 90,000 options to buy
@ $5.25, valued at
$472.5k
|
|
| 02/06/2020 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 4,070 shares
@ $5.13, valued at
$20.9k
|
|
| 09/04/2019 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 2,811 shares
@ $5.43, valued at
$15.3k
|
|
| 06/26/2019 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 44,000 options to buy
@ $0 |
|
| 02/27/2019 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 10,000 shares
@ $0
Paid exercise price by delivering 1,194 shares
@ $11.95, valued at
$14.3k
Granted 58,000 options to buy
@ $11.97, valued at
$694.3k
|
|
| 02/07/2019 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 2,996 shares
@ $11.43, valued at
$34.2k
|
|
| 10/02/2018 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 1,923 shares
@ $0
Paid exercise price by delivering 954 shares
@ $13.92, valued at
$13.3k
|
|
| 09/05/2018 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 2,810 shares
@ $14, valued at
$39.3k
|
|
| 02/28/2018 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 7,000 shares
@ $0
Granted 45,000 options to buy
@ $18.69, valued at
$841.1k
|
|
| 09/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/09/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/30/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/12/2016 |
4
| Sarena Francis Willard (Chief Strategy Officer) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 7,000 shares
@ $0
Granted 35,000 options to buy
@ $49.54, valued at
$1.7M
|
|
| 09/01/2016 |
4
| Sarena Francis Willard (EVP, Gen Counsel and Secretary) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 08/29/2016 |
4
| Sarena Francis Willard (EVP, Gen Counsel and Secretary) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 10,000 shares
@ $0
Granted 60,000 options to buy
@ $43.71, valued at
$2.6M
|
|
| 03/31/2016 |
4
| Sarena Francis Willard (EVP, Gen Counsel and Secretary) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 11/07/2013 |
4
| Sarena Francis Willard (SVP, Gen Counsel & Secretary) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 7,000 options to buy
@ $10.77, valued at
$75.4k
|
|
| 04/23/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/21/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2009 |
4
| Sarena Francis Willard (VP, Gen Counsel & Secy) has filed a Form 4 on FACET BIOTECH CORP |
|